King's College London

Research portal

Real-time whole genome sequencing to guide patient-tailored therapy of SARS-CoV-2 infection

Research output: Contribution to journalArticlepeer-review

Luke Blagdon Snell, Adela Alcolea-Medina, Themis Charalampous, Christopher Alder, Tom G.S. Williams, Flavia Flaviani, Rahul Batra, Prijay Bakrania, Rajeni Thangarajah, Stuart Neil, Claire van Nispen tot Pannerden, Alina Botgros, Emma J. Aarons, Sam T Douthwaite, Jonathan Edgeworth, Gaia Nebbia

Original languageEnglish
JournalClinical Infectious Diseases
Accepted/In press26 Oct 2022


King's Authors


The management of COVID-19 has become more complex due to the expansion of available therapies. The presence of SARS-CoV-2 variants and mutations further complicate treatment due to their differing susceptibilities to therapies. Here we outline the use of real-time whole genome sequencing to characterise infections and guide treatment decisions.

Download statistics

No data available

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454